1. Home
  2. SBSW vs CYTK Comparison

SBSW vs CYTK Comparison

Compare SBSW & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D/B/A Sibanye-Stillwater Limited ADS

SBSW

D/B/A Sibanye-Stillwater Limited ADS

HOLD

Current Price

$13.19

Market Cap

8.8B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.53

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSW
CYTK
Founded
2013
1997
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
SBSW
CYTK
Price
$13.19
$61.53
Analyst Decision
Buy
Strong Buy
Analyst Count
2
15
Target Price
$6.90
$77.87
AVG Volume (30 Days)
4.8M
1.8M
Earning Date
08-28-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,290,132,787.00
$87,211,000.00
Revenue This Year
$14.61
$361.33
Revenue Next Year
$15.74
$65.14
P/E Ratio
N/A
N/A
Revenue Growth
3.11
2609.26
52 Week Low
$3.05
$29.31
52 Week High
$13.40
$69.33

Technical Indicators

Market Signals
Indicator
SBSW
CYTK
Relative Strength Index (RSI) 64.47 46.45
Support Level $12.10 $59.56
Resistance Level $12.81 $67.26
Average True Range (ATR) 0.52 2.35
MACD 0.05 -0.87
Stochastic Oscillator 66.67 23.49

Price Performance

Historical Comparison
SBSW
CYTK

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: